Results 1 to 10 of about 6,061,294 (414)
Strategies to Address Current Challenges in Real-World Evidence Generation in Japan
The generation of real-world evidence (RWE), which describes patient characteristics or treatment patterns using real-world data (RWD), is rapidly growing more popular as a tool for decision-making in Japan.
Thomas Laurent +4 more
doaj +1 more source
Background The epidemiology and payer costs for ankle fractures are not well documented. This study evaluated: (1) the incidence of ankle fracture and ankle surgery following fracture in the US population; and (2) the clinical presentation of patients ...
Mari F. Vanderkarr +5 more
doaj +1 more source
Background Administrative claims data are a valuable source for clinical studies; however, the use of validated algorithms to identify patients is essential to minimize bias.
Takahiro Hirano +6 more
doaj +1 more source
Real world data (RWD) and real world evidence (RWE) are playing increasing roles in health-care decisions. Real world data are routinely employed to support reimbursement and coverage decisions for drugs and devices.
Real World Data Workshop Group CSPS/Health Canada
doaj +1 more source
Factors associated with physician-reported treatment status of patients with osteoarthritis pain
Background Osteoarthritis (OA) is typically associated with pain, but many patients are not treated. Methods This point in time study explored factors associated with treatment status, using logistic regression of data from the Adelphi OA Disease ...
Thomas J. Schnitzer +9 more
doaj +1 more source
Background Time-related bias can lead to misleading conclusions. Properly setting the "time zero" of follow-up is crucial for avoiding these biases. However, the time-zero setting is challenging when comparing users and non-users of a study drug because ...
Ryozo Wakabayashi +4 more
doaj +1 more source
The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the ...
Yuan-jin Zhang +33 more
doaj +1 more source
Background: Danhong injection is widely used for treating ischemic stroke in China. However, its effects on ischemic stroke patients when given along with Western medicines (i.e., the add-on effect) were not well-established.Methods: We searched PubMed ...
Yu Ma +33 more
doaj +1 more source
This study investigated burden of ‘not well-controlled’ asthma, overall and by Global Initiative for Asthma (GINA) Step, among treated asthma patients in Practice Fusion’s research database.
Jonathan Davitte +5 more
doaj +1 more source
BackgroundPancreatic cancer is expected to be the third deadliest cancer in the US in 2021. Evaluation of treatment response in patients with mPDAC necessitates scheduled clinical and radiographic assessments along with monitoring serum CA 19-9 levels ...
Ben George +4 more
doaj +1 more source

